Dimethylamphetamine
| Metrotonin | |
|---|---|
| Molecular structure drawn from PubChem coordinates |
| Physical properties [] | |
|---|---|
| Molecular mass | 163.26 g/mol [1] |
| Predicted LogP | 2.7 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C11H17N |
| IUPAC name | N,N-dimethyl-1-phenylpropan-2-amine |
| SMILES | CC(CC1=CC=CC=C1)N(C)C |
| InChI | InChI=1S/C11H17N/c1-10(12(2)3)9-11-7-5-4-6-8-11/h4-8,10H,9H2,1-3H3 |
| InChIKey | OBDSVYOSYSKVMX-UHFFFAOYSA-N |
| CAS number | 4075-96-1 |
| UNII | IYE3F3MHCU |
| PubChem CID | 20006 |
| Pharmacokinetics[] | |
|---|---|
| Routes of administration | Oral |
Dimethylamphetamine (also known as N,N-dimethylamphetamine, N,N,α-Trimethylphenethylamine, N,N,α-Trimethylbenzeneethanamine, dimethyl(1-phenylpropan-2-yl)amine, J14.522j, PHENETHYLAMINE, N,N,α-TRIMETHYL-, N-methyl-methamphetamine, 1-Phenyl-2-dimethylaminopropane, 2-Dimethylamino-1-phenylpropane or 1-Phenyl-2-dimethylamino-propan) is a prodrug and stimulant substance of the amphetamine class.
Chemistry
Stereochemistry []
Dimethylamphetamine is a racemic mixture of the enantiomers (optical activity ( + / - )).
| Stereoisomerism |
|---|
| Stereoisomers from PubChem |
Druglikeness
Lipinski's rule of five
Dimethylamphetamine matches Lipinski's rule of five.Reagents
There are currently 4 reagent-interactions on DrugsPRO
| Reagent | Color change | Description |
|---|---|---|
| Marquis | no color change | |
| Mecke | brown / green | |
| Mandelin | brown/yellow | |
| Froehde | no color change |
Pharmacology
MeSH Classification
- central nervous system stimulants (M0001063)
Metabolism
Dimethylamphetamine acts as a prodrug for:
| Metabolic pathways [] |
|---|
Subjective effects []
Legal status []
- Australia: Dimethylamphetamine is a Schedule 9.
- United States: Dimethylamphetamine is a Schedule I under the "Controlled Substances Act".
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 20006, Dimethylamphetamine. Accessed November 21, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/20006
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Dimethylamphetamine. UNII: IYE3F3MHCU. Global Substance Registration System. Accessed November 21, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/IYE3F3MHCU
Data sources []
| Source | Status | Updated (UTC) |
|---|---|---|
| dosing | missing (no dosing statistics) | 2026-11-20 06:06:30 |
| drugspro | ok | 2026-11-20 06:06:26 |
| erowid | missing (no Erowid substance of that name) | 2026-11-20 06:06:26 |
| gsrs | ok | 2026-11-20 06:06:26 |
| hmdb | missing (hmdb.ca refused automated access to HMDB0041880) | 2026-11-20 06:06:26 |
| kegg | missing (no KEGG DRUG entry) | 2026-11-20 06:06:31 |
| pubchem | ok | 2026-11-20 06:06:24 |
| missing (no r/tripreports posts mention it) | 2026-11-20 06:06:26 | |
| sider | missing (not in SIDER) | 2026-11-20 06:06:26 |
| structure | ok | 2026-11-20 06:06:26 |
| wikipedia | ok | 2026-11-20 06:06:26 |